RICERCA
AUTORI
RIVISTE
Sfoglia per AUTORE
MERLANO M
Collezione AO Cuneo
Items : 90
Muscle quality and not quantity as a predictor of survival in head and neck squamous cell carcinoma. in Oral oncology / Oral Oncol. 2023 Oct;145:106540. doi: 10.1016/j.oraloncology.2023.106540. Epub 2023 Aug 9.
2023
AO Cuneo
Roberti E; Merlano M; Ravanelli M; Alberti A; Esposito A; Gili R; Spinazzé S; Baré C; Jocollé G; Benasso M; Bertolotti F; Vecchio S; Bacigalupo A; Licitra L; Denaro N; Damico M; Lorini L; Gurizzan C; Alfieri S; Bossi P;
Baseline Cytokine Profile Identifies a Favorable Outcome in a Subgroup of Colorectal Cancer Patients Treated with Regorafenib. in Vaccines / Vaccines (Basel). 2023 Feb 2;11(2):335. doi: 10.3390/vaccines11020335.
2023
AO Cuneo
Abbona A; Ricci V; Paccagnella M; Granetto C; Ruatta F; Cauchi C; Galizia D; Ghidini M; Denaro N; Merlano MC; Garrone O;
Why Oncologists Should Feel Directly Involved in Persuading Patients with Head and Neck Cancer to Quit Smoking. in Oncology / Oncology. 2023;101(4):252-256. doi: 10.1159/000528345. Epub 2022 Dec 20.
2023
AO Cuneo
Bossi P; Garrone O; Galizia D; Abbona A; Paccagnella M; Minei S; Merlano MC; Denaro N;
Effect of Eribulin on Angiogenesis and the Expression of Endothelial Adhesion Molecules. in Anticancer research / Anticancer Res. 2022 Jun;42(6):2859-2867. doi: 10.21873/anticanres.15767.
2022
AO Cuneo
Abbona A; Paccagnella M; Astigiano S; Martini S; Denaro N; Ruatta F; Barbieri O; Merlano M; Garrone O;
How Chemotherapy Affects the Tumor Immune Microenvironment: A Narrative Review. in Biomedicines / Biomedicines. 2022 Jul 28;10(8):1822. doi: 10.3390/biomedicines10081822.
2022
AO Cuneo
Garrone O; Ghidini M; Paccagnella M; Abbona A; Minei S; Denaro N; Galizia D; Ruatta F; Occelli M; Merlano MC;
Circulating Cytokines in Metastatic Breast Cancer Patients Select Different Prognostic Groups and Patients Who Might Benefit from Treatment beyond Progression. in Vaccines / Vaccines (Basel). 2022 Jan 5;10(1):78. doi: 10.3390/vaccines10010078.
2022
AO Cuneo
Paccagnella M; Abbona A; Michelotti A; Geuna E; Ruatta F; Landucci E; Denaro N; Vanella P; Lo Nigro C; Galizia D; Merlano M; Garrone O;
In reply to immune desert in head and neck squamous cell carcinoma: A review of challenges and opportunities for modulating the tumor immune microenvironment. in Oral oncology / Oral Oncol. 2022 Jan;124:105640. doi: 10.1016/j.oraloncology.2021.105640. Epub 2021 Nov 26.
2022
AO Cuneo
Denaro N; Merlano M; Garrone O;
Cytokine Profiling of End Stage Cancer Patients Treated with Immunotherapy. in Vaccines / Vaccines (Basel). 2021 Mar 8;9(3):235. doi: 10.3390/vaccines9030235.
2021
AO Cuneo
Basiricò M; Gammaitoni L; Galizia D; Crosetto N; Bertetto O; Merlotti A; Ruatta F; Denaro N; Fea E; Ricci V; Granetto C; Falletta A; Paccagnella M; Abbona A; Merlano MC; Sangiolo D; Aglietta M; Garrone O;
Complete response to immunotherapy in sinonasal undifferentiated carcinoma. in Tumori / Tumori. 2021 Dec;107(6):NP101-NP104. doi: 10.1177/03008916211026971. Epub 2021 Jul 6.
2021
AO Cuneo
Denaro N; Merlano M; Numico G; Garrone O; Bossi P;
Unusual Fatal Outcome Following Administration of a Combination of anti-PD1 and anti-CTLA4 in Metastatic Renal Cell Carcinoma: Liver Toxicity Case Report and a Literature Review. in European journal of case reports in internal medicine / Eur J Case Rep Intern Med. 2021 Jun 17;8(7):002639. doi: 10.12890/2021_002639. eCollection 2021.
2021
AO Cuneo
Denaro N; Garrone O; Occelli M; Fea E; Granetto C; Merlano MC; Numico G;
Further Understanding of the Immune Microenvironment in Head and Neck Squamous Cell Carcinoma: Implications for Prognosis. in Cancer management and research / Cancer Manag Res. 2021 May 17;13:3973-3980. doi: 10.2147/CMAR.S277907. eCollection 2021.
2021
AO Cuneo
Denaro N; Merlano MC; Lo Nigro C;
Effect of moderate physical exercise on the immune system modulation in patients with breast cancer during preoperative chemotherapy: The NEO-RUNNER study in Journal of Clinical Oncology
2021
AO Cuneo
Ruatta F; Denaro N; Merlano MC; Prina AV; Rubini D; Vanella P; Paccagnella M; Croce N; Falletta A; Abbona A; Garrone O; Vandone AM;
Cytokines performance during nivolumab treatment: A subgroup analysis of NIVACTOR study in Journal of Clinical Oncology
2021
AO Cuneo
De Zarlo L; Fiorino E; Gammaitoni L; Falletta A; Abbona A; Galizia D; Denaro N; Paccagnella M; Aglietta M; Merlano MC; Licitra LF; Sangiolo D; Bossi P;
Exploratory analysis of circulating cytokines in patients with metastatic breast cancer treated with eribulin: the TRANSERI-GONO (Gruppo Oncologico del Nord Ovest) study. in ESMO open / ESMO Open. 2020 Oct;5(5):e000876. doi: 10.1136/esmoopen-2020-000876.
2020
AO Cuneo
Crosetto N; Falletta A; Lo Nigro C; De Angelis C; Vanella P; Geuna E; Abbona A; Vandone AM; Montemurro F; Michelotti A; Paccagnella M; Garrone O; Di Maio M; Merlano M;
Treating patients with cancer amidst the COVID-19 pandemic: experience of a regional hospital in the Piedmont region in northern Italy. in Tumori / Tumori. 2020 Oct;106(5):427-431. doi: 10.1177/0300891620942313. Epub 2020 Jul 23.
2020
AO Cuneo
Crosetto N; Colantonio I; Di Costanzo G; Fea E; Ricci V; Cauchi C; Occelli M; Vandone AM; Granetto C; Vanella P; Ruatta F; Denaro N; Garrone O; Merlano MC;
VEGF-Related Germinal Polymorphisms May Identify a Subgroup of Breast Cancer Patients with Favorable Outcome under Bevacizumab-Based Therapy-A Message from COMET, a French Unicancer Multicentric Study. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2020 Nov 23;13(11):414. doi: 10.3390/ph13110414.
2020
AO Cuneo
Gal J; Milano G; Brest P; Ebran N; Gilhodes J; Llorca L; Dubot C; Romieu G; Desmoulins I; Brain E; Goncalves A; Ferrero JM; Cottu PH; Debled M; Tredan O; Chamorey E; Merlano MC; Lemonnier J; Etienne-Grimaldi MC; Pierga JY;
Immune escape mechanisms in head and neck squamous cell carcinoma and implication for new immunotherapy approach. in Current opinion in oncology / Curr Opin Oncol. 2020 May;32(3):203-209. doi: 10.1097/CCO.0000000000000623.
2020
AO Cuneo
Merlano MC; Denaro N; Garrone O;
Circulating cytokines and outcome in metastatic colorectal cancer patients treated with regorafenib. in World journal of gastrointestinal oncology / World J Gastrointest Oncol. 2020 Mar 15;12(3):301-310. doi: 10.4251/wjgo.v12.i3.301.
2020
AO Cuneo
Ricci V; Granetto C; Falletta A; Paccagnella M; Abbona A; Fea E; Fabozzi T; Lo Nigro C; Merlano MC;
Coronavirus disease 19 (COVID-19) during chemoradiation for locally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC). in Oral oncology / Oral Oncol. 2020 Aug;107:104801. doi: 10.1016/j.oraloncology.2020.104801. Epub 2020 May 14.
2020
AO Cuneo
Russi E; Merlano MC; Merlotti AM; Denaro N;
Coronavirus disease 19 (COVID-19) during chemoradiation for locally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC). in Oral oncology / Oral Oncol. 2020 Aug;107:104801. doi: 10.1016/j.oraloncology.2020.104801. Epub 2020 May 14.
2020
AO Cuneo
Denaro N; Merlotti AM; Merlano MC; Russi E;
The Impact of Locoregional Treatment on Response to Nivolumab in Advanced Platinum Refractory Head and Neck Cancer: The Need Trial. in Vaccines / Vaccines (Basel). 2020 Apr 20;8(2):191. doi: 10.3390/vaccines8020191.
2020
AO Cuneo
Polimeni A; Vici P; Salati M; Ronzino G; Pizzuti L; Cortellini A; Cassano A; Di Dio C; Cirillo A; Mammone G; Roberto M; Cerbelli B; Sciattella P; Pomati G; Mezi S; Botticelli A; Merlano MC; Nuti M; Marchetti P;
Metastatic disease in head & neck oncology. in Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale / Acta Otorhinolaryngol Ital. 2020 Apr;40(SUPPL. 1):S1-S86. doi: 10.14639/0392-100X-suppl.1-40-2020.
2020
ASL Asti
ASL Vercelli
ASL Torino 3
AOU Città della Salute di Torino
AO Cuneo
AOU Alessandria
AOU Novara
Zannetti M; Valente G; Serra A; Scasso F; Prioglio L; Rugiu MG; Prina-Mello A; Pisani S; Masini L; Merlano MC; Piemonte M; Maroldi R; Mancuso M; Magnano M; Lanza GV; Landolfo V; Iasi GA; Krengli M; Genta I; Garzaro M; Galizia D; Fantozzi C; Denaro N; Costanzo A; Della Vecchia L; Conti B; Colombo A; Zigliani A; Cacciola S; et alii...
Expression and subcellular localization of the bromodomain-containing protein 7 is a prognostic biomarker in breast cancer. in Anti-cancer drugs / Anticancer Drugs. 2020 Apr;31(4):423-430. doi: 10.1097/CAD.0000000000000897.
2020
AO Cuneo
Garrone O; Vivenza D; Brizio R; Mantovani F; Del Sal G; Merlano M; Crook T; Lo Nigro C;
Phase III Randomized Study of Induction Chemotherapy Followed by Definitive Radiotherapy + Cetuximab Versus Chemoradiotherapy in Squamous Cell Carcinoma of Head and Neck: The INTERCEPTOR-GONO Study (NCT00999700). in Oncology / Oncology. 2020;98(11):763-770. doi: 10.1159/000507733. Epub 2020 Jul 6.
2020
AO Cuneo
Merlano MC; Denaro N; Vecchio S; Licitra L; Curcio P; Benasso M; Bagicalupo A; Numico G; Russi E; Corvo' R; Bruzzi P;
The impact of locoregional treatment on response to nivolumab in advanced platinum refractory head and neck cancer: The need trial in Journal of Clinical Oncology
2020
AO Cuneo
Marchetti P; Nuti M; Merlano MC; Roberto M; Cirillo A; Mammone G; Cassano A; Di Dio C; Cortellini A; Pizzuti L; Ronzino G; Salati M; Vici P; Sciattella P; Pomati G; Mezi S; Botticelli A;
Difficulties in conducting pure academic research, obstacles in data collection and quality of informations: The example of the INTERCEPTOR study. in Oral oncology / Oral Oncol. 2019 Oct;97:99-104. doi: 10.1016/j.oraloncology.2019.08.019. Epub 2019 Aug 28.
2019
AO Cuneo
Merlano M; Denaro N; Benasso M; Licitra L; Bossi P; Locati L; Vecchio S; Bruzzi P;
Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge 2018" (28-29 November, 2018, Naples, Italy). in Journal for immunotherapy of cancer / J Immunother Cancer. 2019 Nov 29;7(1):332. doi: 10.1186/s40425-019-0798-3.
2019
AO Cuneo
Spranger S; Schalper KA; Pignata S; Paulos CM; Okada H; Odunsi K; Nathan P; Merlano M; Galon J; Gridelli C; Delgoffe GM; Ferris RL; Fox BA; Emens LA; Buonaguro L; Bifulco C; Ascierto PA; Tortora G; Zarour H; Butterfield LH; Puzanov I;
Unexpected response with palliative conventional therapy in head and neck squamous cell carcinoma after anti-programmed death-1 progression. in Head & neck / Head Neck. 2019 Mar;41(3):E42-E47. doi: 10.1002/hed.25418. Epub 2019 Jan 5.
2019
AO Cuneo
Merlano MC; Denaro N;
NK-mediated antibody-dependent cell-mediated cytotoxicity in solid tumors: biological evidence and clinical perspectives. in Annals of translational medicine / Ann Transl Med. 2019 Mar;7(5):105. doi: 10.21037/atm.2019.01.42.
2019
AO Cuneo
Lo Nigro C; Macagno M; Sangiolo D; Bertolaccini L; Aglietta M; Merlano MC;
The renin angiotensin system (RAS) mediates bifunctional growth regulation in melanoma and is a novel target for therapeutic intervention. in Oncogene / Oncogene. 2019 Mar;38(13):2320-2336. doi: 10.1038/s41388-018-0563-y. Epub 2018 Nov 26.
2019
AO Cuneo
Tzakos AG; Proby C; Stebbing J; Fleming C; Szlosarek P; Thompson A; Evans A; O'Neill K; Sim VR; Li S; Harwood C; Matin R; Hajji N; Del Carmen Fernandez-Carranco M; Vega-Rioja A; Merlano M; Lattanzio L; Nigro CL; Weir L; Rao B; Wang H; Renziehausen A; Syed N; Crook T;
Melanoma: the new perspectives from clinical and translational research. in Anti-cancer drugs / Anticancer Drugs. 2019 Jul;30(6):543-553. doi: 10.1097/CAD.0000000000000798.
2019
AO Cuneo
Occelli M; Vandone AM; Cauchi C; Merlano MC;
Long noncoding RNAs as regulators of cancer immunity. in Molecular oncology / Mol Oncol. 2019 Jan;13(1):61-73. doi: 10.1002/1878-0261.12413. Epub 2018 Dec 13.
2019
AO Cuneo
Denaro N; Merlano MC; Lo Nigro C;
Knowing the tumour microenvironment to optimise immunotherapy. in Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale / Acta Otorhinolaryngol Ital. 2019 Feb;39(1):2-8. doi: 10.14639/0392-100X-2481.
2019
AO Cuneo
Merlano MC; Abbona A; Denaro N; Garrone O;
Selection of systemic therapy in patients with locally advanced and recurrent/metastatic head and neck cancer: RAND-based expert opinion by an Italian multidisciplinary panel. in Tumori / Tumori. 2019 Aug 28:300891619868289. doi: 10.1177/0300891619868289.
2019
AO Cuneo
Bonomo P; Benasso M; Buglione M; Ghi MG; Licitra L; Magrini SM; Merlano MC; Presutti L; Ronzino G; Ferrari D;
In response to Ham et al.: Antibiotics effect on outcome in head and neck cancer. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2019 Aug;117:119-120. doi: 10.1016/j.ejca.2019.05.021. Epub 2019 Jul 3.
2019
AO Cuneo
Denaro N; Merlano MC;
Lenvatinib Long-Term Responses in Refractory Thyroid Cancer: Our Mono-Institutional Real-Life Experience with the Multidisciplinary Approach and Review of Literature. in Oncology / Oncology. 2019;97(4):206-210. doi: 10.1159/000501691. Epub 2019 Aug 7.
2019
AO Cuneo
Merlano MC; Borretta G; Corrado L; Bramardi F; Cesario F; Latina A; Denaro N;
Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events. in PloS one / PLoS One. 2019 Mar 20;14(3):e0213934. doi: 10.1371/journal.pone.0213934. eCollection 2019.
2019
AOU Città della Salute di Torino
AO Cuneo
Berruti A; Resteghini C; Magrini SM; Maroldi R; Nicolai P; Tonoli S; Pronzato P; Alfieri S; Ibrahim T; Rossetto C; Carlini P; Merlano M; Conte P; Airoldi M; Bergamini C; Vecchio S; Bonetta A; Triggiani L; Locati LD; Bianchi S; Grisanti S;
How I treat squamous ENT cancer. in ESMO open / ESMO Open. 2019 Jul 16;4(Suppl 2):e000542. doi: 10.1136/esmoopen-2019-000542. eCollection 2019.
2019
AO Cuneo
Merlano MC; Denaro N; Galizia D; Garrone O;
Correlation between values of specific biomarkers and outcome in metastatic colorectal cancer patients treated with regorafenib in Annals of Oncology
2019
AO Cuneo
Ricci V; Falletta A; Granetto C; Paccagnella M; Abbona A; Fea E; Fabozzi T; Lo Nigro C; Merlano M;
Correlation between values of specific biomarkers and outcome in metastatic colorectal cancer patients treated with regorafenib in Annals of Oncology
2019
AO Cuneo
AOU Città della Salute di Torino
Ricci V; Falletta A; Granetto C; Paccagnella M; Abbona A; Fea E; Fabozzi T; Lo Nigro C; Merlano M; Zucchelli G; Marmorino F; Rossini D; Aprile G; Casagrande M; Lonardi S; Murgioni S; Dell'Aquila E; Tomasello G; Moretto R; Antoniotti C; Borelli B; Urbano F; Ronzoni M; Zaniboni A; Manglaviti S; Buonadonna A; Ritorto G; Masi G; Allegrini G; et alii...
Activation of immune response in refractory patients to standard treatment in Journal of Translational Medicine
2019
AO Cuneo
Occelli M; Abbona A; Sangiolo D; Nigro CL; Garrone O; Falletta A; Anna M; Varamo C; Aglietta M; Gammaitoni L; Monteverde M; Merlano M;
Negative prognostic factors and resulting clinical outcome in patients with metastatic renal cell carcinoma included in the Italian nivolumab-expanded access program. in Future oncology (London, England) / Future Oncol. 2018 Jun;14(14):1347-1354. doi: 10.2217/fon-2017-0570. Epub 2018 May 18.
2018
AO Cuneo
Porta C; Procopio G; Cortesi E; Giannarelli D; De Giorgi U; Turci D; Giorgio CG; Ionta MT; Maestri A; Romito S; Zafarana E; Mucciarini C; Merlano M; Sacco C; Favaretto A; Di Costanzo F; Lo Re G; Buti S; Maruzzo M; Galli L; Bracarda S;
DUSP2 methylation is a candidate biomarker of outcome in head and neck cancer. in Annals of translational medicine / Ann Transl Med. 2018 Jul;6(13):271. doi: 10.21037/atm.2018.06.39.
2018
AO Cuneo
Lo Nigro C; Vivenza D; Denaro N; Lattanzio L; Fortunato M; Crook T; Merlano MC;
Rationale for combination of therapeutic antibodies targeting tumor cells and immune checkpoint receptors: Harnessing innate and adaptive immunity through IgG1 isotype immune effector stimulation. in Cancer treatment reviews / Cancer Treat Rev. 2018 Feb;63:48-60. doi: 10.1016/j.ctrv.2017.11.008. Epub 2017 Dec 2.
2018
AO Cuneo
Ferris RL; Lenz HJ; Trotta AM; García-Foncillas J; Schulten J; Audhuy F; Merlano M; Milano G;
Immunotherapy in Head and Neck Squamous Cell Cancer. in Clinical and experimental otorhinolaryngology / Clin Exp Otorhinolaryngol. 2018 Dec;11(4):217-223. doi: 10.21053/ceo.2018.00150. Epub 2018 Jul 6.
2018
AO Cuneo
Merlano MC; Denaro N;
Impact of treatment expertise on the outcome of patients with head and neck cancer treated within 6 randomized trials. in Head & neck / Head Neck. 2018 Dec;40(12):2648-2656. doi: 10.1002/hed.25389. Epub 2018 Nov 17.
2018
AO Cuneo
Dani C; Infante G; Merlano MC; Fallai C; Sanguineti G; Bacigalupo A; Corvò R; Benasso M; Miceli R; Bossi P; Di Giannantonio V; Licitra L;
Activation of immune responses in patients with relapsed-metastatic head and neck cancer (CONFRONT phase I-II trial): Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide. in Clinical and translational radiation oncology / Clin Transl Radiat Oncol. 2018 Aug 13;12:47-52. doi: 10.1016/j.ctro.2018.08.001. eCollection 2018 Au
2018
AO Ordine Mauriziano
AO Cuneo
Corvò R; Russi EG; Vecchio S; Curcio P; Fruttero C; Galizia D; Di Maio M; Denaro N; Fea E; Licitra L; Merlano MC; Merlotti AM;
Incidence of cetuximab-related infusion reaction in head and neck cancer patients: may we predict it? in ESMO open / ESMO Open. 2018 Jun 20;3(4):e000404. doi: 10.1136/esmoopen-2018-000404. eCollection 2018.
2018
AO Cuneo
Merlano MC; Garrone O;
Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study. in Oncotarget / Oncotarget. 2017 Aug 10;8(45):79884-79896. doi: 10.18632/oncotarget.20168. eCollection 2017 Oct 3.
2017
AO Cuneo
Gamucci T; Quadrini S; Palazzo S; Di Cicilia R; Cavanna L; Rubino D; Pinto C; Maiorana L; Iacono C; Imperatori M; Tonini G; Bergo E; Zagonel V; Marchetti L; Pavese I; Chiurazzi B; Carteni G; Magarotto R; Gori S; Plastino F; Barone C; Saracino V; Lorusso V; Farcomeni A; Lucia S; Muscaritoli M; Minardi S; Merlano M; Colucci G; et alii...
Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2017 Oct 1;28(10):2526-2532. doi: 10.1093/annonc/mdx344.
2017
AO Cuneo
Ehrnrooth E; Machiels JH; Solca F; Gibson N; Cong XJ; Krämer N; Dupuis N; Merlano MC; Geoffrois L; Guigay J; Tahara M; Vermorken JB; Haddad RI; Mailliez A; Del Campo JM; Grau JJ; Clement PM; Gauler T; Fayette J; Burtness B; Cohen EEW; Licitra LF;
Elevated basal antibody-dependent cell-mediated cytotoxicity (ADCC) and high epidermal growth factor receptor (EGFR) expression predict favourable outcome in patients with locally advanced head and neck cancer treated with cetuximab and radiotherapy. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2017 May;66(5):573-579. doi: 10.1007/s00262-017-1960-8. Epub 2017 Feb 14.
2017
AO Cuneo
Lattanzio L; Denaro N; Vivenza D; Varamo C; Strola G; Fortunato M; Chamorey E; Comino A; Monteverde M; Lo Nigro C; Milano G; Merlano M;
MicroRNAs role as potential biomarkers and key regulators in melanoma. in Genes, chromosomes & cancer / Genes Chromosomes Cancer. 2017 Jan;56(1):3-10. doi: 10.1002/gcc.22402. Epub 2016 Oct 25.
2017
AO Cuneo
Varamo C; Occelli M; Vivenza D; Merlano M; Lo Nigro C;
Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies. in Oncotarget / Oncotarget. 2017 Feb 7;8(6):9174-9188. doi: 10.18632/oncotarget.13942.
2017
AO Cuneo
Guyot M; Hilmi C; Ambrosetti D; Merlano M; Lo Nigro C; Durivault J; Grépin R; Pagès G;
Prognostic Value of Different Allelic Polymorphism of Aldosterone Synthase Receptor in a Congestive Heart Failure European Continental Ancestry Population. in Archives of medical research / Arch Med Res. 2017 Feb;48(2):156-161. doi: 10.1016/j.arcmed.2017.03.008.
2017
ASL Cuneo 1
AO Cuneo
Lo Nigro C; Vado A; Merlano M; Astesana V; Mussapi F; Testa M; Leto L; Vivenza D; Monteverde M; Feola M;
Eribulin in advanced breast cancer: safety, efficacy and new perspectives. in Future oncology (London, England) / Future Oncol. 2017 Dec;13(30):2759-2769. doi: 10.2217/fon-2017-0283. Epub 2017 Sep 13.
2017
AO Cuneo
Merlano MC; Lingua D; Vandone AM; Vanella P; Miraglio E; Garrone O;
Head and neck cancer: improving outcomes with a multidisciplinary approach. in Cancer management and research / Cancer Manag Res. 2017 Aug 18;9:363-371. doi: 10.2147/CMAR.S115761. eCollection 2017.
2017
AO Cuneo
Lo Nigro C; Denaro N; Merlotti A; Merlano M;
Correlation between the prognostic value of tumor-infiltrating lymphocytes (TILS) and sidedness in colorectal cancer (CC) patients (pts) in Annals of Oncology
2017
AO Cuneo
Granetto C; Ricci V; Fea E; Vivenza D; Lo Nigro C; Fortunato M; Comino A; Merlano M;
Heterogeneity of colon cancer: from bench to bedside. in ESMO open / ESMO Open. 2017 Aug 22;2(3):e000218. doi: 10.1136/esmoopen-2017-000218. eCollection 2017.
2017
AO Cuneo
Garrone O; Ricci V; Fea E; Merlano MC; Granetto C;
Reoxygenation Reverses Hypoxia-related Radioresistance in Head and Neck Cancer Cell Lines. in Anticancer research / Anticancer Res. 2016 May;36(5):2211-5.
2016
AO Cuneo
Lo Nigro C; Merlano M; Gianello L; Russi E; Vivenza D; Monteverde M; Ghiglia A; Cavicchioli F; Astesana V; Tonissi F; Lattanzio L;
Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015. in Journal of translational medicine / J Transl Med. 2016 Jul 25;14(1):65. doi: 10.1186/s12967-016-0791-2.
2016
AOU Città della Salute di Torino
AO Cuneo
AOU Novara
Topalian SL; Taube JM; Drake CG; Pardoll DM; Cheadle C; Cope L; Xu H; Fan J; Pritchard TS; Netto GJ; Anders RA; Danilova L; McMiller TL; Berger AE; Ascierto ML; Formenti S; De Biasio V; Battarra VC; Michelozzi P; Nudo M; Marino C; Bono R; Capuano M; Zappalà A; Passarelli F; Caggiati A; Mastroeni S; Fortes C; Anniciello A; et alii...
Gemcitabine-Based Chemoradiation in the Treatment of Locally Advanced Head and Neck Cancer: Systematic Review of Literature and Meta-Analysis. in The oncologist / Oncologist. 2016 Jan;21(1):59-71. doi: 10.1634/theoncologist.2015-0246. Epub 2015 Dec 28.
2016
AO Cuneo
Vanderveken OM; Szturz P; Specenier P; Merlano MC; Benasso M; Van Gestel D; Wouters K; Van Laer C; Van den Weyngaert D; Peeters M; Vermorken J;
Ethics in oncology: principles and responsibilities declared in the Italian Ragusa statement. in Tumori / Tumori. 2016 Dec 1;102(6):e25-e27. doi: 10.5301/tj.5000582.
2016
AO Ordine Mauriziano
AO Cuneo
Bordonaro R; Labianca R; Micallo G; Fioretto L; Zagonel V; Merlano M; Passalacqua R; Crispino S; Di Costanzo F; De Cicco M; Mancuso A; Omodeo Salè E; Di Maio M; Perrone F; Nicolis F; Iacono C; Spinsanti S; Comandone A; Marchetti P; Aprile G; Caminiti C; Pinto C; Gori S;
Follow-up in Head and Neck Cancer: Do More Does It Mean Do Better? A Systematic Review and Our Proposal Based on Our Experience. in Clinical and experimental otorhinolaryngology / Clin Exp Otorhinolaryngol. 2016 Dec;9(4):287-297. doi: 10.21053/ceo.2015.00976. Epub 2016 Jun 25.
2016
AO Cuneo
Denaro N; Merlano MC; Russi EG;
Prolonged Drainage and Intrapericardial Bleomycin Administration for Cardiac Tamponade Secondary to Cancer-Related Pericardial Effusion. in Medicine / Medicine (Baltimore). 2016 Apr;95(15):e3273. doi: 10.1097/MD.0000000000003273.
2016
AO Cuneo
Silvestris N; Piovano P; Merlano M; Colantonio I; Fea E; Mozzicafreddo A; Cristofano A; Occelli M; Sicuro M; Numico G;
Eribulin in pretreated metastatic breast cancer patients: results of the TROTTER trial-a multicenter retrospective study of eribulin in real life. in SpringerPlus / Springerplus. 2016 Jan 21;5:59. doi: 10.1186/s40064-016-1700-0. eCollection 2016.
2016
ASL Torino 4
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
ASL Biella
ASL Vercelli
ASL Alessandria
AOU Novara
Merlano MC; Polimeni MA; Oletti MV; Lucio F; Airoldi M; De Conciliis E; La Verde N; Vandone AM; Donadio M; Giacobino A; Saggia C; Montemurro F; Garrone O;
Immune-related response criteria: light and shadows. in ESMO open / ESMO Open. 2016 Jul 7;1(4):e000082. doi: 10.1136/esmoopen-2016-000082. eCollection 2016.
2016
AO Cuneo
Garrone O; Occelli M; Merlano M;
How to enhance nonprofit clinical research in a General Hospital in Annals of Oncology
2016
AO Cuneo
Violante S; Merlano MC; Lattanzio L; Giurlanda F; Curcio P;
Tumor-infiltrating lymphocytes (TILs) density as prognostic determinant in stage II colorectal cancer in Annals of Oncology
2016
AO Cuneo
Ricci V; Comino A; Vivenza D; Granetto C; Lo Nigro C; Ferrero M; Merlano MC;
Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2015 Oct;96(1):167-82. doi: 10.1016/j.critrevonc.2015.06.001. Epub 2015 Jul
2015
AO Cuneo
AOU Città della Salute di Torino
Girolomoni G; Langendijk JA; Bensadoun RJ; Pinto C; Pergolizzi S; Denaro N; Licitra L; Merlano MC; Lombardo A; Airoldi M; Buglione M; Bossi P; Numico G; De Sanctis V; Bacigalupo A; Benasso M; Rampino M; Russi EG; Moretto F;
Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2015 Nov;96(2):372-84. doi: 10.1016/j.critrevonc.2015.06.005. Epub 2015 Jun
2015
AO Cuneo
Murphy B; Langendijk JA; Merlano MC; Licitra L; Ripamonti C; Pavanato G; De Sanctis V; Bacigalupo A; Alterio D; Buglione M; Caspiani O; Orlandi E; Gava A; Numico G; Spadola Bissetti M; Merlotti A; Bossi P; Pizzorni N; Russi EG; Denaro N; Schindler A; Sanguineti G;
Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2015 Aug;95(2):191-213. doi: 10.1016/j.critrevonc.2015.03.003. Epub 2015 Mar
2015
AO Cuneo
AOU Città della Salute di Torino
Vermorken JB; Dellinger RP; Ranieri MV; Murphy B; Bernier J; Raber-Durlacher J; Cascio A; Pergolizzi S; Buglione M; Caspiani O; Denaro N; Moretto F; Licitra L; Merlano MC; Ghi MG; Merlotti A; Musso S; De Sanctis V; Bacigalupo A; Crippa F; Bossi P; Russi EG; Numico G; Mirabile A;
The relevance of ADCC for EGFR targeting: A review of the literature and a clinically-applicable method of assessment in patients. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2015 Aug;95(2):179-90. doi: 10.1016/j.critrevonc.2015.02.014. Epub 2015 Mar
2015
AO Cuneo
Merlano M; Lo Nigro C; Tonissi F; Vivenza D; Lattanzio L; Strola G; Maffi M; Milano G; Monteverde M;
Retrospective evaluation of ADCC activity and cetuximab response in KRAS wild-type metastatic colorectal cancer patients (mCRC) in Annals of Oncology
2015
AO Cuneo
Ricci V; Vivenza D; Monteverde M; Strola G; Granetto C; Lo Nigro C; Merlano MC;
Biomarker analysis in recurrent and/or metastatic head and neck squamous cell carcinoma (R/M HNSCC) patients (pts) treated with second-line afatinib versus methotrexate (MTX): LUX-Head & Neck 1 (LUX-H&N1) in Journal of Clinical Oncology
2015
AO Cuneo
Cohen EEW; Licitra LF; Fayette J; Gauler TC; Clement PM; Grau JJ; Del Campo JM; Mailliez A; Haddad RI; Vermorken JB; Tahara M; Guigay J; Geoffrois L; Merlano MC; Dupuis NF; Burtness B; Gibson N; Solca F; Ehrnrooth E; Machiels J-PH;
Real-world study of everolimus in advanced progressive neuroendocrine tumors. in The oncologist / Oncologist. 2014 Sep;19(9):966-74. doi: 10.1634/theoncologist.2014-0037. Epub 2014 Aug 12.
2014
AOU San Luigi di Orbassano
AO Cuneo
Delle Fave G; Falconi M; Colao A; Berruti A; Appetecchia M; Cartenì G; Campana D; Cassano A; Ambrosio MR; Fontana A; Pusceddu S; Spada F; Funaioli C; Antonuzzo L; Chiara S; Merlano M; Cascinu S; Pastorelli D; Faggiano A; Nobili E; Zaniboni A; Brizzi MP; Nuzzo C; Riccardi F; Tomassetti P; Lugli F; Zatelli MC; Luppi G; de Braud F; et alii...
Non coding RNAs in head and neck squamous cell carcinoma (HNSCC): a clinical perspective. in Anticancer research / Anticancer Res. 2014 Dec;34(12):6887-96.
2014
AO Cuneo
Lo Nigro C; Russi EG; Merlano MC; Denaro N;
State-of-the-art and emerging treatment options in the management of head and neck cancer: news from 2013. in Oncology / Oncology. 2014;86(4):212-29. doi: 10.1159/000357712. Epub 2014 May 10.
2014
AO Cuneo
Denaro N; Russi EG; Adamo V; Merlano MC;
Dysphagia in Head and Neck Cancer Patients: Pretreatment Evaluation, Predictive Factors, and Assessment during Radio-Chemotherapy, Recommendations. in Clinical and experimental otorhinolaryngology / Clin Exp Otorhinolaryngol. 2013 Sep;6(3):117-26. doi: 10.3342/ceo.2013.6.3.117. Epub 2013 Sep 4.
2013
AO Cuneo
Denaro N; Merlano MC; Russi EG;
Swallowing dysfunction in head and neck cancer patients treated by radiotherapy: review and recommendations of the supportive task group of the Italian Association of Radiation Oncology. in Cancer treatment reviews / Cancer Treat Rev. 2012 Dec;38(8):1033-49. doi: 10.1016/j.ctrv.2012.04.002. Epub 2012 Apr 27.
2012
AO Cuneo
Bernier J; Bonomo P; Merlano MC; Zurlo V; Chiesa F; Sanguineti G; Paiar F; Ricardi U; Ruo Redda MG; De Sanctis V; Pergolizzi S; Franco P; Alterio D; Corvò R; Merlotti A; Russi EG;
The role of antiangiogenic agents in the treatment of head and neck cancer. in Oncology / Oncology. 2012;83(2):108-16. doi: 10.1159/000339542. Epub 2012 Jul 9.
2012
AO Cuneo
Denaro N; Russi EG; Colantonio I; Adamo V; Merlano MC;
The Role of p53 and MDM2 in Head and Neck Cancer. in ISRN otolaryngology / ISRN Otolaryngol. 2011 Dec 7;2011:931813. doi: 10.5402/2011/931813. Print 2011.
2011
AO Cuneo
Denaro N; Lo Nigro C; Natoli G; Russi EG; Adamo V; Merlano MC;
Expression profiling and long lasting responses to chemotherapy in metastatic gastric cancer. in International journal of oncology / Int J Oncol. 2010 Nov;37(5):1219-28. doi: 10.3892/ijo_00000773.
2010
AO Cuneo
Merlano M; Comino A; Borghi F; Ceppi M; Gallo F; Heouaine A; Monteverde M; Riba M; Lattanzio L; Tonissi F; Garrone O; Lo Nigro C;
Impact of erythropoietin on the effects of irradiation under hypoxia. in Journal of cancer research and clinical oncology / J Cancer Res Clin Oncol. 2009 Nov;135(11):1615-23. doi: 10.1007/s00432-009-0609-1. Epub 2009 Jun 5.
2009
AO Cuneo
Merlano M; Formento P; Milano G; Etienne-Grimaldi MC; Riba M; Lattanzio L; Tonissi F; Catarsi P; Monteverde M; Fischel JL; Maffi M; Lo Nigro C;
The combination of docetaxel and the somatostatin analogue lanreotide on androgen-independent docetaxel-resistant prostate cancer: experimental data. in BJU international / BJU Int. 2008 Aug 5;102(5):622-7. doi: 10.1111/j.1464-410X.2008.07706.x. Epub 2008 May 20.
2008
AO Cuneo
Lo Nigro C; Merlano M; Milano G; Formento P; Maffi M; Fischel JL;
The cisplatin-irradiation combination suggests that apoptosis is not a major determinant of clonogenic death. in Anti-cancer drugs / Anticancer Drugs. 2007 Jul;18(6):659-67. doi: 10.1097/CAD.0b013e328087388f.
2007
AO Cuneo
Fruttero A; Russi EG; Taricco E; Arnolfo E; Lo Nigro C; Lucio F; Ribero S; Comino A; Merlano M; Ungari S;
Single-agent pegylated liposomal doxorubicin (Caelix) in chemotherapy pretreated non-small cell lung cancer patients: a pilot trial. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2002 Jan;35(1):59-64. doi: 10.1016/s0169-5002(01)00269-0.
2002
AO Cuneo
Gasco M; Ciura PL; Garrone O; Mariani G; Costanzo GD; Granetto C; Castiglione F; Numico G; Ostellino O; Porcile G; Merlano M;
Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity. in Cancer research / Cancer Res. 2002 Apr 1;62(7):2072-6.
2002
AO Cuneo
Merlano M; Yulug I; Numico G; Hiller L; Smith P; Sullivan A; Heath V; Bell AK; Gasco M; Farrell PJ; Tavassoli M; Gusterson B; Crook T;
Best supportive care in non-small cell lung cancer: is there a role for radiotherapy and chemotherapy? in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2001 Jun;32(3):213-26. doi: 10.1016/s0169-5002(00)00222-1.
2001
AO Cuneo
Numico G; Russi E; Merlano M;
Gemcitabine, cisplatin, and radiation in advanced, unresectable squamous cell carcinoma of the head and neck: a feasibility study. in American journal of clinical oncology / Am J Clin Oncol. 2001 Dec;24(6):618-22. doi: 10.1097/00000421-200112000-00019.
2001
AO Cuneo
Rosso R; Marchetti G; Santelli A; Vitale V; Pallestrini E; Ricci I; Benasso M; Numico G; Corvò R; Merlano M; Sanguineti G;
[The treatment of laryngeal cancer. Chemotherapeutic treatment]. in Recenti progressi in medicina / Recenti Prog Med. 1998 Dec;89(12):647-50.
1998
AO Cuneo
Merlano M; Garrone O;